Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-24

Clinical Trial Update: A Multi-center Acute Efficacy Trial of GFX For Reduction of Glabellar Furrowing [NA]

View source ↗

Summary

A multi-center acute efficacy trial evaluating GFX for reducing glabellar furrowing and forehead wrinkles has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GFX

Snippet

Sponsor: Advanced Cosmetic Intervention | Conditions: Glabellar Furrowing, Forehead Wrinkles | NA | Status: COMPLETED